Cholangiocarcinoma With <i>FGFR</i> Genetic Aberrations: A Unique Clinical Phenotype.

Jain, Apurva; Borad, Mitesh J; Kelley, Robin Kate; Wang, Ying; Abdel-Wahab, Reham; Meric-Bernstam, Funda; Baggerly, Keith A; Kaseb, Ahmed Omar; Al-Shamsi, Humaid O; Ahn, Daniel H; DeLeon, Thomas; Bocobo, Andrea Grace; Bekaii-Saab, Tanios; Shroff, Rachna T; Javle, Milind

Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype.

Jain, Apurva; Borad, Mitesh J; Kelley, Robin Kate; Wang, Ying; Abdel-Wahab, Reham; Meric-Bernstam, Funda; Baggerly, Keith A; Kaseb, Ahmed Omar; Al-Shamsi, Humaid O; Ahn, Daniel H; DeLeon, Thomas; Bocobo, Andrea Grace; Bekaii-Saab, Tanios; Shroff, Rachna T; Javle, Milind.

Afiliação

Jain A; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Borad MJ; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Kelley RK; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Wang Y; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Abdel-Wahab R; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Meric-Bernstam F; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Baggerly KA; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Kaseb AO; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Al-Shamsi HO; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Ahn DH; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
DeLeon T; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Bocobo AG; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Bekaii-Saab T; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Shroff RT; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke
Javle M; Apurva Jain, Ying Wang, Reham Abdel-Wahab, Funda Meric-Bernstam, Keith A. Baggerly, Ahmed Omar Kaseb, Humaid O. Al-shamsi, Rachna T. Shroff, and Milind Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Mitesh J. Borad and Thomas DeLeon, Mayo Clinic, Scottsdale, AZ; Robin Kate Ke

JCO Precis Oncol ; 2: 1-12, 2018 Nov.

Article em En | MEDLINE | ID: mdl-35135097

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2018 Tipo de documento: Article